Evotec SE

Evotec SE is a global leader in drug discovery and development, dedicated to providing innovative solutions for the pharmaceutical and biotechnology industries. Established with a vision to transform the way medicines are developed, Evotec combines cutting-edge technology with extensive scientific expertise.

The company operates through a unique business model that integrates various stages of drug development, from early-stage research to clinical trials. This holistic approach allows Evotec to offer tailored services to its partners, ensuring efficient and effective pathways to bring new therapies to market.

With a strong emphasis on collaboration, Evotec has formed strategic alliances with numerous pharmaceutical companies, academic institutions, and research organisations worldwide. These partnerships enhance its capabilities and expand its reach in the global market.

Evotec’s core activities include:

• Drug Discovery: Utilizing advanced technologies and methodologies to identify potential drug candidates.
• Preclinical Development: Conducting rigorous testing and evaluation of drug candidates before clinical trials.
• Clinical Development: Managing and executing clinical trials to assess the safety and efficacy of new therapies.
• Biologics Development: Focusing on the development of biologic drugs, including monoclonal antibodies and vaccines.

Committed to sustainability and ethical practices, Evotec prioritises responsible research and development processes. The company also invests in talent development, fostering a culture of innovation and excellence among its employees.

Headquartered in Germany, Evotec has a significant presence in the UK, where it continues to expand its operations and contribute to the local economy. With a dedicated workforce and a passion for science, Evotec SE is poised to lead the future of drug development.